Moreover, in lung cancer, DNAJC12 levels are upregulated, while DNAJC12 knockdown reduces the malignant properties and tumor growth of lung cancer cells in vitro and in vivo by inhibiting activation of β-catenin [194]. This evidence concerns the gene DNAJC12 and lung cancer.